Key result
Premeal insulin boosts myocardial microvascular blood flow ~33% vs postmeal dosing in T1D.
Why the study?
It was unknown whether prandial insulin timing affects vascular function and myocardial microvascular blood flow in people with type 1 diabetes.
Does premeal insulin administration improve myocardial microvascular blood flow in people with type 1 diabetes?
RCT (n=36)
Single-blind
1:1 randomised crossover
No
Does premeal insulin administration improve myocardial microvascular blood flow in people with type 1 diabetes?
Appropriately timed premeal insulin administration in type 1 diabetes lowers postprandial blood glucose and acutely increases myocardial microvascular blood flow.
Answers are grounded in this paper and cite their sources.
Premeal insulin timing may improve microvascular perfusion and glycemia in type 1 diabetes; extends limited RCT evidence on prandial optimization.
Aims/hypothesis We aimed to evaluate whether prandial insulin timing affects vascular function in people with type 1 diabetes. Our hypothesis was that premeal insulin administration would lead to greater myocardial microvascular blood flow (MBF) via blunting postprandial hyperglycaemia. Methods People with type 1 diabetes between 18 and 35 years of age with BMI <30 kg/m 2 underwent two protocols with a 1:1 randomised crossover design wherein prandial insulin was injected either 15 min before or 15 min after meal intake began. To provide a physiological comparison, age-, sex- and BMI-matched control participants completed one study where they consumed the same meal but received no exogenous insulin. Glucose, insulin, vascular function (including ultrasound measures of myocardial and skeletal muscle microvascular perfusion, aortic stiffness, brachial artery endothelial function) and biomarkers of systemic inflammation and endothelial dysfunction were assessed at baseline and then 2 h after meal ingestion within each protocol. The primary outcome was change in myocardial MBF within each protocol. Study personnel assessing outcomes were masked to group assignment. Results Eighteen people with type 1 diabetes and 18 matched control participants were analysed within each protocol. Glucose area under the curve was significantly greater ( p =0.015) in the postmeal insulin study compared with the premeal insulin study in participants with type 1 diabetes. Myocardial microvascular flow velocity significantly increased ( p =0.031) with premeal insulin administration in people with type 1 diabetes and this consequently led to greater myocardial MBF ( p =0.044). There were no changes in myocardial MBF within the other protocols. Changes in vital signs were similar between all protocols. Conclusions/interpretation Appropriately timed premeal insulin led to lower postprandial blood glucose along with increased myocardial MBF in people with type 1 diabetes. Further work is needed to determine the underlying aetiology of these changes. Trial registration ClinicalTrials.gov NCT04730882
No takes yet. Share an insight, caveat, or question.
Horton et al. (2026) conducted an RCT in Type 1 diabetes (n=36). Premeal insulin administration vs. Postmeal insulin administration was evaluated on Change in myocardial microvascular blood flow (MBF) (Fold change 1.333, 95% CI 1.008-1.764, p=0.044). Premeal insulin administration increased myocardial microvascular blood flow and lowered postprandial blood glucose compared to postmeal administration in people with type 1 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: